Search
A collaboration between MSK and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.
In honor of Minority Cancer Awareness Month, Dr. Brown shared information about cancer disparities, the importance of cancer screening, and MSK's health equity work.
Twelve students have successfully defended their dissertations and will receive their PhD degrees at Commencement on May 14.
Learn about a clinical trial at Memorial Sloan Kettering that is using plasma donated by MSK employees who have recovered from COVID-19.
Hepatic arterial infusion chemotherapy given to colorectal cancer patients with liver metastases extends their survival by almost two years, according to a large retrospective study from Memorial Sloan Kettering recently published in the JCO.
Annually, GSK awards fellowships to two second-year students and six first-year students based on academic achievement in different elements of the curriculum.
To help some patients to overcome leukemia, MSK doctors are calling upon patients’ microbiomes — the vast ecosystems of microorganisms that live within us, especially the gut. These microbes appear to help some patients recover from bone marrow and stem cell transplants.
Seven GSK PhD students were awarded nine competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).
Researchers from Memorial Sloan Kettering Cancer Center to present the latest advances in blood cancer during The American Society of Hematology 2024 annual meeting.
About a third of patients with metastatic breast cancer don’t respond well to the standard anti-estrogen therapies; to find ways to better treat those patients, Memorial Sloan Kettering Cancer Center is studying three new selective estrogen receptor down-regulators (SERDs) in clinical trials.